Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
SOLS vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
SOLS vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $12.35B | $8.43B |
| Revenue (TTM) | $3.89B | $8.64B |
| Net Income (TTM) | $207M | $399M |
| Gross Margin | 32.2% | 19.8% |
| Operating Margin | 18.8% | 9.4% |
| Forward P/E | 28.8x | 12.5x |
| Total Debt | $2.43B | $5.08B |
| Cash & Equiv. | $534M | $566M |
Quick Verdict: SOLS vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SOLS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.1%, EPS growth -44.0%
- 60.8% 10Y total return vs EMN's 35.4%
- 3.1% NII/revenue growth vs EMN's -6.7%
EMN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 1.36, yield 4.5%
- Lower volatility, beta 1.36, Low D/E 84.1%, current ratio 1.37x
- Beta 1.36, yield 4.5%, current ratio 1.37x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% NII/revenue growth vs EMN's -6.7% | |
| Value | Lower P/E (12.5x vs 28.8x) | |
| Quality / Margins | 6.1% margin vs EMN's 4.6% | |
| Stability / Safety | Beta 1.36 vs SOLS's 1.47, lower leverage | |
| Dividends | 4.5% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +60.8% vs EMN's +2.3% | |
| Efficiency (ROA) | 3.8% ROA vs EMN's 2.6%, ROIC 14.8% vs 6.7% |
SOLS vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SOLS vs EMN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SOLS leads this category, winning 4 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 2.2x SOLS's $3.9B. Profitability is closely matched — net margins range from 6.1% (SOLS) to 4.6% (EMN).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.9B | $8.6B |
| EBITDAEarnings before interest/tax | $907M | $1.2B |
| Net IncomeAfter-tax profit | $207M | $399M |
| Free Cash FlowCash after capex | $154M | $498M |
| Gross MarginGross profit ÷ Revenue | +32.2% | +19.8% |
| Operating MarginEBIT ÷ Revenue | +18.8% | +9.4% |
| Net MarginNet income ÷ Revenue | +6.1% | +4.6% |
| FCF MarginFCF ÷ Revenue | — | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -27.4% | -40.8% |
Valuation Metrics
EMN leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 66% valuation discount to SOLS's 52.2x P/E. On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than SOLS's 14.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.3B | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $14.2B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | 52.19x | 17.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.76x | 12.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.59x |
| EV / EBITDAEnterprise value multiple | 14.94x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 3.18x | 0.96x |
| Price / BookPrice ÷ Book value/share | 8.97x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | 19.87x |
Profitability & Efficiency
SOLS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
SOLS delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $7 for EMN. EMN carries lower financial leverage with a 0.84x debt-to-equity ratio, signaling a more conservative balance sheet compared to SOLS's 1.76x. On the Piotroski fundamental quality scale (0–9), EMN scores 5/9 vs SOLS's 1/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.5% | +6.7% |
| ROA (TTM)Return on assets | +3.8% | +2.6% |
| ROICReturn on invested capital | +14.8% | +6.7% |
| ROCEReturn on capital employed | +18.6% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 5 |
| Debt / EquityFinancial leverage | 1.76x | 0.84x |
| Net DebtTotal debt minus cash | $1.9B | $4.5B |
| Cash & Equiv.Liquid assets | $534M | $566M |
| Total DebtShort + long-term debt | $2.4B | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | 22.37x | 2.22x |
Total Returns (Dividends Reinvested)
SOLS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SOLS five years ago would be worth $16,082 today (with dividends reinvested), compared to $7,163 for EMN. Over the past 12 months, SOLS leads with a +60.8% total return vs EMN's +2.3%. The 3-year compound annual growth rate (CAGR) favors SOLS at 17.2% vs EMN's 1.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +57.9% | +15.8% |
| 1-Year ReturnPast 12 months | +60.8% | +2.3% |
| 3-Year ReturnCumulative with dividends | +60.8% | +3.4% |
| 5-Year ReturnCumulative with dividends | +60.8% | -28.4% |
| 10-Year ReturnCumulative with dividends | +60.8% | +35.4% |
| CAGR (3Y)Annualised 3-year return | +17.2% | +1.1% |
Risk & Volatility
Evenly matched — SOLS and EMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMN is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than SOLS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SOLS currently trades 91.5% from its 52-week high vs EMN's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.47x | 1.36x |
| 52-Week HighHighest price in past year | $84.99 | $84.18 |
| 52-Week LowLowest price in past year | $40.43 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates SOLS as "Buy" and EMN as "Buy". Consensus price targets imply 4.9% upside for EMN (target: $77) vs -3.5% for SOLS (target: $75). EMN is the only dividend payer here at 4.47% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $75.00 | $77.29 |
| # AnalystsCovering analysts | 4 | 35 |
| Dividend YieldAnnual dividend ÷ price | — | +4.5% |
| Dividend StreakConsecutive years of raises | — | 12 |
| Dividend / ShareAnnual DPS | — | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% |
SOLS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMN leads in 1 (Valuation Metrics). 1 tied.
SOLS vs EMN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SOLS or EMN a better buy right now?
For growth investors, Solstice Advanced Materials Inc.
(SOLS) is the stronger pick with 3. 1% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Solstice Advanced Materials Inc. (SOLS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SOLS or EMN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Solstice Advanced Materials Inc. at 52. 2x. On forward P/E, Eastman Chemical Company is actually cheaper at 12. 5x.
03Which is the better long-term investment — SOLS or EMN?
Over the past 5 years, Solstice Advanced Materials Inc.
(SOLS) delivered a total return of +60. 8%, compared to -28. 4% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: SOLS returned +60. 8% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SOLS or EMN?
By beta (market sensitivity over 5 years), Eastman Chemical Company (EMN) is the lower-risk stock at 1.
36β versus Solstice Advanced Materials Inc. 's 1. 47β — meaning SOLS is approximately 9% more volatile than EMN relative to the S&P 500. On balance sheet safety, Eastman Chemical Company (EMN) carries a lower debt/equity ratio of 84% versus 176% for Solstice Advanced Materials Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SOLS or EMN?
By revenue growth (latest reported year), Solstice Advanced Materials Inc.
(SOLS) is pulling ahead at 3. 1% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Solstice Advanced Materials Inc. grew EPS -44. 0% year-over-year, compared to -46. 5% for Eastman Chemical Company. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SOLS or EMN?
Solstice Advanced Materials Inc.
(SOLS) is the more profitable company, earning 6. 1% net margin versus 5. 4% for Eastman Chemical Company — meaning it keeps 6. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOLS leads at 18. 8% versus 10. 6% for EMN. At the gross margin level — before operating expenses — SOLS leads at 32. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SOLS or EMN more undervalued right now?
On forward earnings alone, Eastman Chemical Company (EMN) trades at 12.
5x forward P/E versus 28. 8x for Solstice Advanced Materials Inc. — 16. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMN: 4. 9% to $77. 29.
08Which pays a better dividend — SOLS or EMN?
In this comparison, EMN (4.
5% yield) pays a dividend. SOLS does not pay a meaningful dividend and should not be held primarily for income.
09Is SOLS or EMN better for a retirement portfolio?
For long-horizon retirement investors, Eastman Chemical Company (EMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield). Both have compounded well over 10 years (EMN: +35. 4%, SOLS: +60. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SOLS and EMN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SOLS is a mid-cap quality compounder stock; EMN is a small-cap deep-value stock. EMN pays a dividend while SOLS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.